View Full List
Hikma Pharmaceuticals Plc ADR
Streaming Delayed Price
Updated: 10:18 AM EST, Feb 20, 2024
Add to My Watchlist
All News about Hikma Pharmaceuticals Plc ADR
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
January 08, 2024
Guardant Health, Inc.
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
June 12, 2023
The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...
Junshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa Region
December 26, 2022
Friday Markets News
March 25, 2022
Methane leaks in the Permian Basin are 6 times higher than estimates.
Bio-Thera Solutions and Hikma Pharmaceuticals Announce Exclusive Commercialization and License Agreement for BAT2206 in the US, a Proposed Biosimilar Referencing Stelara® (ustekinumab)
August 27, 2021
Bio-Thera Solutions, Ltd.
June 25, 2021
The stock market tried for another record after yesterday's late blowout over the infrastructure deal.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions